The advances in melanoma staging and treatment

The advances in melanoma staging and treatment

Julie Scott, DNP
Julie Scott, DNP

Melanoma Staging

Once a diagnosis of melanoma has been made, the oncologist may order imaging studies to see if melanoma has spread to other areas of the body. Melanoma is staged from stage 0 to IV, with melanoma becoming more advanced the higher the stage. 

When the biopsy has resulted with melanoma, and staging studies have been completed, the oncologist can develop a treatment plan. 

Melanoma Treatment

Surgery is often used as a treatment for melanoma, with the type of surgery being a wide local excision (WLE). During this type of surgery, the entire melanoma lesion along with a wide amount of healthy tissue surrounding it is taken out, to be sure the entire melanoma has been removed. The full amount of tissue that needs to be removed depends upon the size and thickness of the melanoma lesion. 

Along with a WLE, a sentinel lymph node biopsy is often done. This surgery identifies the first lymph node closest to the melanoma using a special dye. This helps the surgeon identify it and remove the lymph node for evaluation of the presence of cancer cells. 

In addition to surgery, other treatments may be recommended based on the stage of the cancer. A commonly used treatment is immunotherapy. Immunotherapy medications are usually intravenous medications that work by helping the immune system see any melanoma cells in the body. This allows the immune system to help fight against melanoma. Examples of immunotherapy include:

  • Yervoy
  • Opdivo
  • Keytruda

Targeted treatment

Targeted treatment for BRAF mutations is available as well. Some people may benefit from the use of these after surgery, to help reduce the risk of melanoma returning. These medications work by interfering with the BRAF pathway melanoma cells use to grow. Examples of BRAF targeted therapy include a medication called dabrafenib. 

Early stage melanoma and Standard chemotherapy

Standard chemotherapy and radiation are rarely used for early stage melanoma. 

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Why cancerGO and Why Now? -Bridging the Gap in Cancer Conversations
January 26, 2023

Cancer conversations are often fragmented due to the sheer amount of information that needs to be communicated. Diagnoses, treatments, medications, and progress can all be tricky topics for many people involved in the cancer care process. Add to this the complexity of dealing with multiple healthcare providers and family members…

cancerGO Founders

author

Articles
Prostate cancer: who is at risk and how to catch it early
November 8, 2022

What is Prostate cancer? Prostate cancer is common cancer in men. About 13% of men will be diagnosed with prostate cancer during their lifetime. It’s important to know that prostate cancer is very treatable, even in its advanced stages.  Risk Factors The biggest risk factor men face for prostate cancer…

Julie Scott, DNP

author

Articles
Lymphoma staging and how they affect treatment options
November 8, 2022

Lymphoma Staging Once the biopsy confirms lymphoma, and all of the imaging has been done, the oncologist can stage the cancer. Staging describes how advanced the lymphoma is, and helps the oncologist determine the best treatment.  Lymphoma staging is different from the staging for solid tumors such as lung cancer…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice